Fresenius Seamless
Care of Louisiana

an ESRD Seamless Care Organization

Fresenius Seamless Care of Louisiana, LLC

Certain dialysis facilities in Louisiana have chosen to participate in Fresenius Seamless Care of Louisiana, an ESRD Seamless Care Organization (ESCO) in the Medicare Comprehensive ESRD Care model. See below for a listing of ESCO dialysis facilities in Louisiana.

We’re Working to Improve Your Care

The goal of an ESCO is for dialysis facilities, nephrologists, and other health care providers to communicate and work together closely, so they can deliver high-quality care that meets the patient’s individual needs and preferences. ESCOs may be rewarded for providing their patients with higher quality, more coordinated care.

You Can Still Choose Any
Dialysis Facility, Doctor or Hospital

An ESCO Patient’s Medicare benefits do not change. An ESCO is not a Medicare Advantage plan, a Health Maintenance Organization (HMO) plan, or an insurance plan of any kind.

ESCO Patients still have the right to use any dialysis facility, provider or hospital that accepts Medicare, at any time. A doctor may continue to recommend that an ESCO Patient see particular doctors or providers for their specific health needs, but it is always the patient’s choice about which provider they use or dialysis facility or hospital they visit.

Questions or Concerns?

If you have questions or concerns, you can:

  • E-mail us at, call us at 1-844-209-9093, or bring it up next time you are in your provider’s office.
  • You can also call 1-800-MEDICARE (1-800-633-4227) and tell the representative you are calling about ESCOs.
  • TTY users should call 1-877-486-2048.

ESCO Leadership Team and Participants

Primary Contact

Eric Maaske

Fresenius Health Partners

Clinical Leadership Contact

Terry Ketchersid, MD

Integrated Care Group,
Fresenius Medical Care North America

Andrew Aronson, MD FACEP

Fresenius Health Partners
Health Services

Scott Dickison

Integrated Care Group

Maria Radonova

Integrated Care Group,
Fresenius Health Partners


Participants Owner

Fresenius Medical Care LaPlace, LLC

Fresenius Medical Care Chalmette

Baton Rouge Vascular Access, LLC

Fresenius Medical Care Capital City, LLC




Kidney and Hypertension Associates

  • Brandond Bean
  • David Powers

Kidney Care of Louisiana (PPS)

  • Robin Bennett
  • Rajat Gulati

Mississippi Nephrologists, LLC

  • Binu Pannachan

New Orleans Nephrology Associates, LLC

  • Ashwin Jaikishen
  • Friedrichs Harris
  • Gabrie Rivera-Rodriguez
  • Hu Kim
  • Jill Lindberg
  • Miguel Molina
  • Steven Morris
  • Tra Le

Nephrology and Wellness

  • Kimberly Williams

Nephrology Center of Excellence (PPS)

  • Chad Rossitter
  • Matthew Blaine Theriot
  • Justin Lege

Renal Associates of Baton Rouge, LLC

  • Ashley Haney, NP
  • Christopher P. Luscy
  • Damodar Kumbala, MD, FASN
  • Daniel E. Marsh
  • Dawn Hebert
  • Emily Burke, NP
  • James E. Yegge
  • James S. Sim, MD
  • Jennifer B. Louque, NP
  • Jeremy C. O'Neal
  • Jessica Tran
  • Jones Samuel
  • Judson H. Jones
  • Kenneth G. Smith
  • Mahesh Basireddy
  • Matthew Foy
  • Michael W. Roppolo
  • Natasha Lewis
  • Raynold Corona
  • Robert P. Landry
  • Ronald L. Cassano
  • Sarah E. Apking, NP
  • William B. Murrill
  • Rachel F. Gray

S. Tahseen Rab, MD AP LLC

  • Farida Baig
  • S. Tahseen Rab

Southwest Mississipi Nephrology

  • Paul Dykes
  • Richard Miller
  • Holly Kimbrell

NNA of Louisiana, LLC


Fresenius Medical Care Holdings, Inc.
Fresenius Seamless Care
PO Box 162970
Austin, TX 78716-2970

Joint Ventures

Fresenius Medical Care LaPlace, LLC
Fresenius Medical Care Chalmette
Fresenius Medical Care Capital City, LLC
Fresenius Medical Care Lake Forest, LLC

For more information about joint ventures, call 844‑209‑9093.

Governing Body

Renal Associates Of Baton Rouge, Daniel E. Marsh, MD
Fresenius Kidney Care, Timothy Berberovich
Fresenius Health Partners, Michael P. Martin
Independent Consumer Advocate, Peter (Pete) Sullivan

Quality Performance

Performance Year 2017 will be reported in winter 2018.

Financial Performance

Performance Year 2017 will be reported in winter 2018.